Preferred Label : Xydalba;
Origin ID : M000617203;
Related record
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-10.html
2022
false
false
false
Canada
French
insurance, health, reimbursement
Xydalba
dalbavancin
drug evaluation
canada
skin diseases, bacterial
acute disease
soft tissue infections
anti-bacterial agents
infusions, intravenous
dalbavancin
treatment outcome
---
